Doctors in India prescribe unapproved fertility drugBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7418.768-d (Published 02 October 2003) Cite this as: BMJ 2003;327:768
- Ganapati Mudur
- New Delhi
Doctors in India have been accused of prescribing women a drug that has been illegally promoted and marketed for infertility treatment by a major drug company in the country.
In an editorial in its September edition, the drug industry journal, the Monthly Index of Medical Specialities India, has accused Sun Pharmaceuticals in Bombay of promoting an anticancer drug, letrozole, for infertility treatment in women.
Letrozole has been approved globally for the treatment of breast cancer in post-menopausal women, but it is not approved for any other use in any country. But Sun Pharmaceuticals has allegedly been promoting …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial